Maven Clinic

End-to-end virtual care for women and families — fertility and family building (IVF/IUI, egg freezing, adoption, surrogacy, and now oncofertility with Color Health), maternity and newborn care, parenting and pediatrics, and menopause/midlife — delivered through a telehealth provider network of 30+ specialties in 35+ languages across 175+ countries, wrapped with care advocacy, benefits and fertility-spend administration (Maven Wallet / Maven Managed Benefit), and a managed fertility clinic network. Sold to employers (Amazon, AT&T, Harvard), health plans, and Medicaid programs; since May 2026 also a nationwide direct-to-consumer clinic combining GLP-1 weight care, hormone/menopause care, and pay-per-visit specialty care.

Stated: be the single front door for women's and family health across the whole reproductive lifecycle, replacing point solutions, with a ten-year Series F roadmap emphasizing value-based fertility care, Medicaid and fully-insured expansion, midlife/menopause, and global reach. Inferred: (1) prep for an IPO — the 2025 executive bench is uniformly public-market-experienced and Ryder says Maven aims to go public, though she declined timing at JPM 2026; (2) diversify beyond the employer channel into DTC subscriptions (GLP-1s from $150/month, hormone care) announced March 2026 and launched nationwide May 20, 2026, then resell those offerings back through employers/health plans starting 2027; (3) differentiate on data and evidence — Oura biometrics, women-specific GLP-1 protocols, and a Clinical Research Institute to defend clinical credibility against cheaper telehealth rivals; (4) deepen into the money flow of care — claims & payments product hiring, Maven Managed Benefit, and partial-risk value-based contracts moving toward outcomes-based fertility pricing; (5) consolidate the category via M&A and partnerships (Wellthy caregiving, Color Health oncofertility) into a unified family-care platform.

Category-defining brand and scale in women's/family health: the largest specialized virtual network (30+ specialties, 175+ countries, 35 languages), 2,000+ employer/payer clients including marquee global accounts like Amazon, deep multi-year benefits integrations (Maven Wallet, Managed Benefit, managed fertility clinic network) that are costly to rip out, a decade of longitudinal women's health data being formalized into published evidence via the Clinical Research Institute, exclusive-feeling clinical partnerships (Oura FDA-listed ovulation prediction, Color Health oncofertility), and blue-chip investor backing. Winning Amazon's global fertility contract away from Progyny signals pricing and breadth advantages over point solutions; the emerging claims/payments layer would raise switching costs further.